Algalif
Biotechnology ResearchReykjanesbær, Iceland11-50 Employees
Algalif operates in biotechnology research and produces natural astaxanthin from Haematococcus pluvialis at a cGMP-compliant indoor facility in Reykjanesbær, Iceland. The company markets ASTALIF, a premium natural astaxanthin ingredient intended for nutraceuticals with potential benefits for brain health, eye health, healthy aging, cardiovascular health, muscle endurance and recovery, and skin health. Its product range includes 5%, 10% and 15% oleoresins for soft gelatin capsules and topical oils, algal biomass for capsules, bulk softgel capsules for white-label applications, and branded supplements for retail. Algalif emphasizes quality, safety and sustainability, with 100% natural, non-GMO, gluten-free, allergen-free products, HACCP-compliant downstream processing, and operations powered entirely by renewable geothermal energy; the algae are cultivated with pure Icelandic water, and the company holds Novel Food and GRAS statuses in the US, plus Halal and Kosher certifications. The company is based in Iceland and employs between 11 and 50 people, and it maintains a website at algalif.com.